Effects of Brain-derived Neurotrophic Factor on 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in Monkeys

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914 · see citing works

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Burns, R. S., Chiueh, C. C., Markey, S. P., Ebert, M. H., Jacobowitz, D. M., & Kopin, I. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.14.4546 · Cited by 2,149 · see citing works

Purification of a new neurotrophic factor from mammalian brain.

Barde, Y. A., Edgar, D., & Thoenen, H. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01207.x · Cited by 1,822 · see citing works

BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra

Hyman, C., Hofer, M., Barde, Y., Juhasz, M., Yancopoulos, G. D., Squinto, S. P., & Lindsay, R. M. (1991) · Nature · doi:10.1038/350230a0 · Cited by 1,494 · see citing works

The <i>trk</i> Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth Factor

Kaplan, D. R., Hempstead, B. L., Martin-Zanca, D., Chao, M. V., & Parada, L. F. (1991) · Science · doi:10.1126/science.1850549 · Cited by 1,379 · see citing works

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

Davis, G. C., Williams, A. C., Markey, S. P., Ebert, M. H., Caine, E. D., Reichert, C. M., & Kopin, I. J. (1979) · Psychiatry Research · doi:10.1016/0165-1781(79)90006-4 · Cited by 1,377 · see citing works

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

Nicklas, W. J., Vyas, I. L., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,266 · see citing works

Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family

Hohn, A., Leibrock, J., Bailey, K., & Barde, Y.-A. (1990) · Nature · doi:10.1038/344339a0 · Cited by 1,145 · see citing works

Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF

Kaplan, D. R., Martı́n-Zanca, D., & Parada, L. F. (1991) · Nature · doi:10.1038/350158a0 · Cited by 1,059 · see citing works

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

Langston, J. W., Forno, L. S., Rebert, C. S., & Irwin, I. (1984) · Brain Research · doi:10.1016/0006-8993(84)90777-7 · Cited by 922 · see citing works

trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor

Squinto, S. P., Stitt, T. N., Aldrich, T. H., Davis, S. H., Blanco, S. M., Radziejewski, C. H., Glass, D. J., Masiakowski, P., Furth, M. E., Valenzuela, D. M., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90395-f · Cited by 830 · see citing works

The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor

Soppet, D., Escandon, E., Maragos, J., Middlemas, D. S., Raid, S. W., Blair, J., Burton, L. E., Stanton, B. R., Kaplan, D. R., Hunter, T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90396-g · Cited by 820 · see citing works

Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section

Sendtner, M., Holtmann, B., Kolbeck, R., Thoenen, H., & Barde, Y. (1992) · Nature · doi:10.1038/360757a0 · Cited by 706 · see citing works

Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain.

Ernfors, P., Ibáñez, C. F., Ebendal, T., Olson, L., & Persson, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5454 · Cited by 700 · see citing works

Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death

Qiao, Y., Elliott, J. L., & Snider, W. D. (1992) · Nature · doi:10.1038/360753a0 · Cited by 670 · see citing works

The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's Disease

Tetrud, J. W., & Langston, J. W. (1989) · Science · doi:10.1126/science.2502843 · Cited by 635 · see citing works

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

Turski, L., Bressler, K., Rettig, K.-J., Löschmann, P. A., & Wachtel, H. (1991) · Nature · doi:10.1038/349414a0 · Cited by 546 · see citing works

Evidence for calcium-reducing and excitoprotective roles for the calcium-binding protein calbindin-1328k in cultured hippocampal neurons

Mattson, M. P., Rychlik, B., Chu, C., & Christakost, S. (1991) · Neuron · doi:10.1016/0896-6273(91)90120-o · Cited by 524 · see citing works

Brain-derived neurotrophic factor prevents neuronal death in vivo

Hofer, M., & Barde, Y. (1988) · Nature · doi:10.1038/331261a0 · Cited by 497 · see citing works

Brain‐Derived Neurotrophic Factor Protects Dopamine Neurons Against 6‐Hydroxydopamine and N‐Methyl‐4‐Phenylpyridinium Ion Toxicity: Involvement of the Glutathione System

Spina, M. B., Squinto, S. P., Miller, J. M., Lindsay, R. M., & Hyman, C. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08880.x · Cited by 460 · see citing works

Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death

Oppenheim, R. W., Yin, Q.-W., Prevette, D. M., & Yan, Q. (1992) · Nature · doi:10.1038/360755a0 · Cited by 447 · see citing works

1-Methyl-4-phenylpyridinium ion (MPP+): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra

Langston, J. W., Irwin, I., Langston, E. B., & Forno, L. S. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90293-3 · Cited by 435 · see citing works

Fibroblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitecture

Mattson, M., Murrain, M., Guthrie, P., & Kater, S. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-11-03728.1989 · Cited by 409 · see citing works

Function and evolution in the NGF family and its receptors

Ebendal, T. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490320402 · Cited by 344 · see citing works

Blood-Brain Barrier Penetration and in Vivo Activity of an NGF Conjugate

Friden, P. M., Walus, L. R., Watson, P. M., Doctrow, S. R., Kozarich, J. W., Bäckman, C. M., Bergman, H., Hoffer, B. J., Bloom, F. E., & Granholm, A. (1993) · Science · doi:10.1126/science.8420006 · Cited by 327 · see citing works

Nerve growth factor affects11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (Case Report)

Olson, L., Nordberg, A. K., von Holst, H., Bäckman, L., Ebendal, T., Alafuzoff, I. I., Amberla, K., Hartvig, P., Herlitz, A., Lilja, A., et al. (1992) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02257624 · Cited by 323 · see citing works

Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis

Jellinger, K., Kienzl, E., Rumpelmair, G., Riederer, P., Stachelberger, H., Ben‐Shachar, D., & Youdim, M. B. H. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08362.x · Cited by 313 · see citing works

Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

Bankiewicz, K. S., Oldfield, E. H., Chiueh, C. C., Doppman, J. L., Jacobowitz, D. M., & Kopin, I. J. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90431-5 · Cited by 308 · see citing works

Keeping track of neurotrophin receptors

Bothwell, M. A. (1991) · Cell · doi:10.1016/0092-8674(91)90540-f · Cited by 292 · see citing works

Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain

Knüsel, B., Beck, K., Winslow, J. W., Rosenthal, A., Burton, L., Widmer, H., Nikolics, K., & Hefti, F. F. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-11-04391.1992 · Cited by 278 · see citing works

Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo.

Altar, C. A., Boylan, C. B., Jackson, C., Hershenson, S., Miller, J., Wiegand, S. J., Lindsay, R. M., & Hyman, C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11347 · Cited by 275 · see citing works

ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, AND MOTONEURONE DISEASE: ABIOTROPIC INTERACTION BETWEEN AGEING AND ENVIRONMENT?

Calne, D. B., McGeer, E. G., Eisen, A., & Spencer, P. S. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90469-1 · Cited by 255 · see citing works

Studies on the Neurotoxicity of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine: Inhibition of NAD‐Linked Substrate Oxidation by Its Metabolite, 1‐Methyl‐4‐Phenylpyridinium

Vyas, I. L., Heikkila, R. E., & Nicklas, W. J. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb01768.x · Cited by 242 · see citing works

Neurochemical and behavioral effects of systematic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat

Chiueh, C. C., Markey, S. P., Burns, R. S., Johannessen, J. N., Pert, A., & Kopin, I. J. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90221-8 · Cited by 224 · see citing works

Regulation of microtubule composition and stability during nerve growth factor-promoted neurite outgrowth.

Black, M. M., Aletta, J. M., & Greene, L. (1986) · The Journal of Cell Biology · doi:10.1083/jcb.103.2.545 · Cited by 154 · see citing works

MK‐801 Prevents 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine‐Induced Parkinsonism in Primates

Zuddas, A., Oberto, G., Vaglini, F., Fascetti, F., Fornai, F., & Corsini, G. U. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09429.x · Cited by 154 · see citing works

V. Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

Castagnoli, N., Chiba, K., & Trevor, A. J. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90063-3 · Cited by 153 · see citing works

Genetically modified cells: applications for intracerebral grafting

Gage, F. H., Kawaja, M. D., & Fisher, L. J. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90156-o · Cited by 147 · see citing works

COGNITIVE AND MOTOR DEFICITS IN THE ACQUISITION OF AN OBJECT RETRIEVAL/DETOUR TASK IN MPTP-TREATED MONKEYS

Taylor, J. R., Elsworth, J. D., Roth, R. H., Sladek, J. R., & Redmond, D. E. (1990) · Brain · doi:10.1093/brain/113.3.617 · Cited by 140 · see citing works

Oral levodopa dose‐response study in MPTP‐induced hemiparkinsonian monkeys: Assessment with a new rating scale for monkey parkinsonism

Kurlan, R., Kim, M. H., & Gash, D. M. (1991) · Movement Disorders · doi:10.1002/mds.870060205 · Cited by 117 · see citing works

The Role of Brain-derived Neurotrophic Factor in Transient Forebrain Ischemia in the Rat Brain

Tsukahara, T., Yonekawa, Y., Tanaka, K., Ohara, O., Watanabe, S., Kimura, T., Nishijima, T., & Taniguchi, T. (1994) · Neurosurgery · doi:10.1227/00006123-199402000-00016 · Cited by 111 · see citing works

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF

Elsworth, J. D., Deutch, A. Y., Redmond, D. E., Sladek, J. R., & Roth, R. H. (1987) · Brain Research · doi:10.1016/0006-8993(87)90211-3 · Cited by 102 · see citing works

Mechanisms of cholecystokinin-induced protection of cultured cortical neurons against N-methyl-d-aspartate receptor-mediated glutamate cytotoxicity

Tamura, Y., Sato, Y., Akaike, A., & Shiomi, H. (1992) · Brain Research · doi:10.1016/0006-8993(92)91691-7 · Cited by 85 · see citing works

Evidence that the blockade of mitochondrial respiration by the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) involves binding at the same site as the respiratory inhibitor, rotenone

Krueger, M. J., Singer, T. P., Casida, J. E., & Ramsay, R. R. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91442-u · Cited by 85 · see citing works

Delivery of Trophic Factors to the Primate Brain

Kordower, J. H., Mufson, E. J., Granholm, A., Hoffer, B. J., & Friden, P. M. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1169 · Cited by 84 · see citing works

Chapter 62 Transplantation of embryonic marmoset dopaminergic neurons to the corpus striatum of marmosets rendered parkinsonian by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Fine, A., Hunt, S. P., Oertel, W. H., Nomoto, M., Chong, P. N., Bond, A., Waters, C. M., Temlett, J. A., Annett, L. E., Dunnett, S. B., et al. (1988) · Progress in brain research · doi:10.1016/s0079-6123(08)60321-0 · Cited by 81 · see citing works

Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls

Taylor, J. R., Elsworth, J. D., Roth, R. H., Sladek, J. R., Collier, T. J., & Redmond, D. E. (1991) · Experimental Brain Research · doi:10.1007/bf00229411 · Cited by 75 · see citing works

Neural mechanisms mediating 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the monkey: Relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptake

Mitchell, I., Cross, A. J., Sambrook, M. A., & Crossman, A. R. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90013-3 · Cited by 72 · see citing works

Cell culture of cryopreserved human fetal cerebral cortical and hippocampal neurons: neuronal development and responses to trophic factors

Mattson, M. P., & Rychlik, B. (1990) · Brain Research · doi:10.1016/0006-8993(90)91462-p · Cited by 72 · see citing works

Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatum

Elsworth, J. D., Deutch, A. Y., Redmond, D. E., Sladek, J. R., & Roth, R. H. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90359-6 · Cited by 67 · see citing works

Brain-derived neurotrophic factor pretreatment exerts a partially protective effect against glutamate-induced neurotoxicity in cultured rat cortical neurons

Shimohama, S., Tamura, Y., Akaike, A., Tsukahara, T., Ohara, O., Watanabe, S., & Kimura, J. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90856-g · Cited by 62 · see citing works

The time course and magnitude of spontaneous recovery of parkinsonism produced by intracarotid administration of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐tetrahydropyridine to monkeys

Kurlan, R., Kim, M. H., & Gash, D. M. (1991) · Annals of Neurology · doi:10.1002/ana.410290618 · Cited by 56 · see citing works

Behavioral Effects of MPTP Administration in the Vervet Monkey

Taylor, J. R., Elsworth, J. D., Roth, R. H., Sladek, J. R., & Redmond, D. E. (1994) · Springer eBooks · doi:10.1007/978-1-4899-1447-7_6 · Cited by 55 · see citing works

Alterations of a 200 kDa Neurofilament in the Rat Hippocampus after Forebrain Ischemia

Kaku, Y., Yonekawa, Y., Tsukahara, T., Ogata, N., Kimura, T., & Taniguchi, T. (1993) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1993.54 · Cited by 52 · see citing works

MPTP-induced parkinsonism in monkeys: Mechanism of action, selectivity and pathophysiology

Schultz, W. (1988) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(88)90055-9 · Cited by 42 · see citing works

Production of human thyroid-stimulating hormone in Chinese hamster ovary cells

Watanabe, S., Hayashizaki, Y., Endo, Y., Hirono, M., Takimoto, N., Tamaki, M., Teraoka, H., Miyal, K., & Matsubara, K. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90528-6 · Cited by 33 · see citing works

On Guiding Principles for Animal Experiments Using Nonhuman Primates

Honjo, S. (1986) · Primate Research · doi:10.2354/psj.2.109 · Cited by 30 · see citing works

Grafts and Growth Factors in CNS

Olson, L. (1990) · Stereotactic and Functional Neurosurgery · doi:10.1159/000100220 · Cited by 21 · see citing works

Effect of nerve growth factor on delayed neuronal death and microtubule-associated protein 2 after transient cerebral ischaemia in the rat

Tanaka, K., Tsukahara, T., Kaku, Y., Hashimoto, N., Yonekawa, Y., Ogata, N., Kimura, T., & Taniguchi, T. (1994) · Journal of Clinical Neuroscience · doi:10.1016/0967-5868(94)90088-4 · Cited by 9 · see citing works

Brain-derived neurotrophic factor in neurodegenerative diseases

Zuccato, C., & Cattaneo, E. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.54 · Cited by 947 · see citing works

Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease

Murer, M. G., Yan, Q., & Raisman-Vozari, R. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00014-9 · Cited by 874 · see citing works

Potential therapeutic uses of BDNF in neurological and psychiatric disorders

Nagahara, A. H., & Tuszynski, M. H. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3366 · Cited by 867 · see citing works

The role of neuronal growth factors in neurodegenerative disorders of the human brain

Connor, B. J., & Dragunow, M. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00004-6 · Cited by 534 · see citing works

BDNF as a Promising Therapeutic Agent in Parkinson’s Disease

Palasz, E., Wysocka, A., Gasiorowska, A., Chalimoniuk, M., Niewiadomski, W., & Niewiadomska, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031170 · Cited by 504 · see citing works

Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra

Howells, D. W., Porritt, M. J., Wong, J. Y. F., Batchelor, P. E., Kalnins, R., Hughes, A. J., & Donnan, G. A. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7483 · Cited by 513 · see citing works

Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man

Gerlach, M., & Riederer, P. F. (1996) · Journal of Neural Transmission · doi:10.1007/bf01291788 · Cited by 496 · see citing works

Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease

Maswood, N., Young, J., Tilmont, E. M., Zhang, Z., Gash, D. M., Gerhardt, G. A., Grondin, R., Roth, G. S., Mattison, J. A., Lane, M. A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405831102 · Cited by 383 · see citing works

The MPTP model of Parkinson's disease

Smeyne, R. J., & Jackson-Lewis, V. R. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.09.017 · Cited by 377 · see citing works

Emerging therapies in Parkinson disease — repurposed drugs and new approaches

Elkouzi, A., Vedam‐Mai, V., Eisinger, R. S., & Okun, M. S. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0155-7 · Cited by 304 · see citing works

Intraventricular Brain-Derived Neurotrophic Factor Reduces Infarct Size after Focal Cerebral Ischemia in Rats

Schäbitz, W.-R., Schwab, S., Spranger, M., & Hacke, W. (1997) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1097/00004647-199705000-00003 · Cited by 322 · see citing works

Tyrosine Hydroxylase and Parkinson’s Disease

Haavik, J., & Toska, K. (1998) · Molecular Neurobiology · doi:10.1007/bf02741387 · Cited by 263 · see citing works

Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism

Faherty, C. J., Shepherd, K. R., Herasimtschuk, A., & Smeyne, R. J. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.08.008 · Cited by 241 · see citing works

Cellular, molecular, and clinical mechanisms of action of deep brain stimulation—a systematic review on established indications and outlook on future developments

Jakobs, M., Fomenko, A., Lozano, A. M., & Kiening, K. L. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809575 · Cited by 229 · see citing works

Brain‐derived neurotrophic factor mediates an excitoprotective effect of dietary restriction in mice

Duan, W., Guo, Z., & Mattson, M. P. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00071.x · Cited by 187 · see citing works

Dietary Restriction Stimulates BDNF Production in the Brain and Thereby Protects Neurons Against Excitotoxic Injury

Duan, W., Lee, J., Guo, Z., & Mattson, M. P. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:16:1:1 · Cited by 183 · see citing works

Gene Therapy for Parkinson’s Disease, An Update

Axelsen, T. M., & Woldbye, D. P. D. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-181331 · Cited by 175 · see citing works

BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation

Hu, Y., & Russek, S. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05237.x · Cited by 161 · see citing works

Brain-derived neurotrophic factor

Benarroch, E. E. (2015) · Neurology · doi:10.1212/wnl.0000000000001507 · Cited by 135 · see citing works

Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons

Porritt, M. J., Batchelor, P. E., & Howells, D. W. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.030 · Cited by 135 · see citing works

Brain-derived neurotrophic factor as a drug target for CNS disorders

Pezet, S., & Malcangio, M. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.5.391 · Cited by 132 · see citing works

Brain Derived Neurotrophic Factor: A novel neurotrophin involved in psychiatric and neurological disorders

Balaratnasingam, S., & Janča, A. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.01.006 · Cited by 131 · see citing works

The Role of Astrocytes in the Neurorepair Process

Chiareli, R. A., Carvalho, G. A., Marques, B. L., Mota, L. S., Oliveira‐Lima, O. C., Gomes, R. M., Birbrair, A., Gomez, R. S., Simão, F., Klempin, F., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.665795 · Cited by 126 · see citing works

Estrogen and SERM neuroprotection in animal models of Parkinson's disease

Morissette, M., Al-Sweidi, S., Callier, S., & Paolo, T. D. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.04.008 · Cited by 122 · see citing works

The Mechanisms by Which the Ketone Body D-β-Hydroxybutyrate May Improve the Multiple Cellular Pathologies of Parkinson's Disease

Norwitz, N. G., Hu, M. T., & Clarke, K. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00063 · Cited by 110 · see citing works

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level

Kupsch, A. R., Sautter, J., Schwarz, J., Riederer, P. F., Gerlach, M., & Oertel, W. H. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00917-1 · Cited by 110 · see citing works

Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain

Bustos, G. A., Abarca, J., Campusano, J. M., Bustos, V., Noriega, V., & Aliaga, E. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.05.002 · Cited by 96 · see citing works

Ultrasound-responsive neurotrophic factor-loaded microbubble- liposome complex: Preclinical investigation for Parkinson's disease treatment

Lin, C., Lin, Y.-C., Huang, C.-Y., Wu, S.-R., Chen, C., & Liu, H.-L. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.044 · Cited by 94 · see citing works

Panax ginseng is neuroprotective in a novel progressive model of Parkinson's disease

Kampen, J. M. V., Baranowski, D. C., Shaw, C. A., & Kay, D. G. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.11.012 · Cited by 91 · see citing works

Therapeutic Potential of Neurotrophic Factors in Neurodegenerative Diseases

Levy, Y. S., Gilgun‐Sherki, Y., Melamed, E., & Offen, D. (2005) · BioDrugs · doi:10.2165/00063030-200519020-00003 · Cited by 90 · see citing works

Serum level of brain-derived neurotrophic factor in Parkinson's disease: a meta-analysis

Jiang, L., Zhang, H., Wang, C., Ming, F., Shi, X., & Yang, M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.07.010 · Cited by 86 · see citing works

Secretion of brain‐derived neurotrophic factor from brain microvascular endothelial cells

Wang, H., Ward, N., Boswell, M., & Katz, D. M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04682.x · Cited by 81 · see citing works

Role of BDNF in Central Motor Structures and Motor Diseases

He, Y., Zhang, X., Yung, W., Zhu, J., & Wang, J. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8466-y · Cited by 81 · see citing works

Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degeneration

Baydyuk, M., Nguyen, M. T., & Xu, B. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.12.018 · Cited by 80 · see citing works

Neurotrophin Signaling and Stem Cells—Implications for Neurodegenerative Diseases and Stem Cell Therapy

Pramanik, S., Sulistio, Y. A., & Heese, K. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0214-7 · Cited by 77 · see citing works

Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease

Liu, M., Xue, Y., Liu, C., Liu, Y.-H., Diao, H., Wang, Y., Pan, Y.-P., & Chen, L. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00835 · Cited by 72 · see citing works

Pgc-1α Overexpression Downregulates Pitx3 and Increases Susceptibility to MPTP Toxicity Associated with Decreased Bdnf

Clark, J., Silvaggi, J. M., Kiselak, T., Zheng, K., Clore, E. L., Dai, Y., Bass, C. E., & Simon, D. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048925 · Cited by 70 · see citing works

Intracerebroventricular 4-Methylcatechol (4-MC) Ameliorates Chronic Pain Associated with Depression-Like Behavior via Induction of Brain-Derived Neurotrophic Factor (BDNF)

Fukuhara, K., Ishikawa, K., Yasuda, S., Kishishita, Y., Kim, H.-K., Kakeda, T., Yamamoto, M., Norii, T., & Ishikawa, T. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9782-2 · Cited by 70 · see citing works

Transforming growth factor‐β1 enhances expression of brain‐derived neurotrophic factor and its receptor, TrkB, in neurons cultured from rat cerebral cortex

Sometani, A., Kataoka, H., Nitta, A., Fukumitsu, H., Nomoto, H., & Furukawa, S. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1229 · Cited by 69 · see citing works

Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGs

Pornnoppadol, G., Bond, L. G., Lucas, M. J., Zupancic, J. M., Kuo, Y., Zhang, B., Greineder, C. F., & Tessier, P. M. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.09.008 · Cited by 70 · see citing works

Engineered BDNF producing cells as a potential treatment for neurologic disease

Deng, P., Anderson, J. D., Yu, A. S., Annett, G., Fink, K. D., & Nolta, J. A. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2016.1183641 · Cited by 68 · see citing works

Differential effects of GDNF and BDNF on cultured ventral mesencephalic neurons

Feng, L., Wang, C.-Y., Jiang, H., Oho, C., Mizuno, K., Dugich‐Djordjevic, M. M., & Lu, B. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00015-7 · Cited by 66 · see citing works

Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic science and clinical studies

Chmielarz, P., & Saarma, M. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00120-3 · Cited by 66 · see citing works

Potential Therapeutic Effects of Neurotrophins for Acute and Chronic Neurological Diseases

Cai, J., Hua, F., Yuan, L., Tang, W., Lu, J., Yu, S., Wang, X., & Hu, Y. (2014) · BioMed Research International · doi:10.1155/2014/601084 · Cited by 66 · see citing works

7,8‐dihydroxyflavone Ameliorates Motor Deficits Via Suppressing α ‐synuclein Expression and Oxidative Stress in the MPTP ‐induced Mouse Model of Parkinson's Disease

Li, X., Dai, C., Chen, L., Zhou, W., Han, H., & Dong, Z. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12555 · Cited by 66 · see citing works

Secretion of brain‐derived neurotrophic factor from PC12 cells in response to oxidative stress requires autocrine dopamine signaling

Wang, H., Yuan, G., Prabhakar, N. R., Boswell, M. V., & Katz, D. M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03572.x · Cited by 66 · see citing works

Attenuation of MPTP neurotoxicity by rolipram, a specific inhibitor of phosphodiesterase IV

Yang, L., Calingasan, N. Y., Lorenzo, B. J., & Beal, M. F. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.02.010 · Cited by 65 · see citing works

The effects of motor rehabilitation training on clinical symptoms and serum BDNF levels in Parkinson’s disease subjects

Angelucci, F., Piermaria, J., Gelfo, F., Shofany, J., Tramontano, M., Fiore, M., Caltagirone, C., & Peppe, A. (2016) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0322 · Cited by 64 · see citing works

Focused ultrasound enhanced intranasal delivery of brain derived neurotrophic factor produces neurorestorative effects in a Parkinson’s disease mouse model

Ji, R., Smith, M., Niimi, Y., Karakatsani, M. E., Murillo, M. F., Jackson-Lewis, V. R., Przedborski, S., & Konofagou, E. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-55294-5 · Cited by 64 · see citing works

The Role of Brain-Derived Neurotrophic Factor Signaling in Central Nervous System Disease Pathogenesis

Dou, S.-H., Cui, Y., Huang, S.-M., & Zhang, B. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.924155 · Cited by 63 · see citing works

CART peptide promotes the survival of hippocampal neurons by upregulating brain-derived neurotrophic factor

Wu, B., Hu, S., Yang, M. H., Pan, H., & Zhu, S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.06.117 · Cited by 63 · see citing works

Striatal dopamine transporter binding correlates with serum BDNF levels in patients with striatal dopaminergic neurodegeneration

Ziebell, M., Khalid, U., Klein, A. B., Aznar, S., Thomsen, G., Jensen, P., & Knudsen, G. M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.11.010 · Cited by 62 · see citing works

D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation

Li, Y., Liu, W., Li, L., & Hölscher, C. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.11.050 · Cited by 62 · see citing works

Glia cell number modulates sensitivity to MPTP in mice

Smeyne, M., Jiao, Y., Shepherd, K. R., & Smeyne, R. J. (2005) · Glia · doi:10.1002/glia.20233 · Cited by 61 · see citing works

Dopamine D1–D2 Receptor Heteromer in Dual Phenotype GABA/Glutamate-Coexpressing Striatal Medium Spiny Neurons: Regulation of BDNF, GAD67 and VGLUT1/2

Perreault, M. L., Fan, T., Alijaniaram, M., O’Dowd, B. F., & George, S. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033348 · Cited by 60 · see citing works

Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease

Stahl, K., Mylonakou, M. N., Skare, Ø., Amiry-Moghaddam, M. R., & Torp, R. (2011) · Brain Research · doi:10.1016/j.brainres.2010.12.090 · Cited by 59 · see citing works

Pharmacologically active microcarriers delivering BDNF within a hydrogel: Novel strategy for human bone marrow-derived stem cells neural/neuronal differentiation guidance and therapeutic secretome enhancement

Kandalam, S., Sindji, L., Delcroix, G. J.-R., Violet, F., Garric, X., André, E. M., Schiller, P. C., Venier‐Julienne, M., Rieux, A. D., Guicheux, J., et al. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.11.030 · Cited by 57 · see citing works

Omega-3 Deficiency and Neurodegeneration in the Substantia Nigra: Involvement of Increased Nitric Oxide Production and Reduced BDNF Expression

Cardoso, H. D., Santos Junior, E. F. D., de Santana, D. F., Gonçalves-Pimentel, C., Angelim, M. K., Isaac, A. R., Lagranha, C. J., Guedes, R. C. A., Beltrão, E. I., Morya, E., et al. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.12.023 · Cited by 55 · see citing works

Exercise does not protect against MPTP-induced neurotoxicity in BDNF happloinsufficent mice

Gerecke, K. M., Jiao, Y., Pagala, V., & Smeyne, R. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043250 · Cited by 53 · see citing works

Neurotrophic factors hold promise for the future of Parkinson’s disease treatment: is there a light at the end of the tunnel?

Nasrolahi, A., Mahmoudi, J., Akbarzadeh, A., Karimipour, M., Sadigh‐Eteghad, S., Salehi, R., & Farhoudi, M. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0040 · Cited by 52 · see citing works

Synucleinopathy-associated pathogenesis in Parkinson’s disease and the potential for brain-derived neurotrophic factor

Miller, K. M., Mercado, N. M., & Sortwell, C. E. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00179-6 · Cited by 51 · see citing works

Brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in Parkinson's disease and age of onset

Hong, C., Liu, H.-C., Liu, T., Lin, C., Cheng, C., & Tsai, S. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.09.009 · Cited by 50 · see citing works

Gene Therapy for Neurological Disorders: Challenges and Future Prospects for the Use of Growth Factors for the Treatment of Parkinsons Disease

Manfredsson, F. P., Okun, M. S., & Mandel, R. J. (2009) · Current Gene Therapy · doi:10.2174/156652309789753400 · Cited by 46 · see citing works

Serum concentration and clinical significance of brain-derived neurotrophic factor in patients with Parkinson’s disease or essential tremor

Huang, Y., Yun, W., Zhang, M., Luo, W., & Zhou, X. (2018) · Journal of International Medical Research · doi:10.1177/0300060517748843 · Cited by 46 · see citing works

Intranasal gene delivery for treating Parkinson’s disease: overcoming the blood–brain barrier

Aly, A. E.-E., & Waszczak, B. L. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1069815 · Cited by 45 · see citing works

The development of encapsulated cell technologies as therapies for neurological and sensory diseases

Zanin, M., Pettingill, L. N., Harvey, A. R., Emerich, D., Thanos, C. G., & Shepherd, R. K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.021 · Cited by 45 · see citing works

4-Methylcatechol Increases Brain-Derived Neurotrophic Factor Content and mRNA Expression in Cultured Brain Cells and in Rat Brain In Vivo

Nitta, A., Ito, M., Fukumitsu, H., Ohmiya, M., Ito, H., Sometani, A., Nomoto, H., Furukawa, Y., & Furukawa, S. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35237-1 · Cited by 45 · see citing works

Sphingosine-1-Phosphate Receptors Modulators Decrease Signs of Neuroinflammation and Prevent Parkinson’s Disease Symptoms in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model

Pépin, É., Jalinier, T., Lemieux, G. L., Massicotte, G., & Cyr, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00077 · Cited by 42 · see citing works

A dual-hit animal model for age-related parkinsonism

Boger, H. A., Granholm, A., McGinty, J. F., & Middaugh, L. D. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.013 · Cited by 43 · see citing works

Serum BDNF discriminates Parkinson’s disease patients with depression from without depression and reflect motor severity and gender differences

Huang, Y., Huang, C., Zhang, Q., Wu, W., & Sun, J. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10299-3 · Cited by 41 · see citing works

Use of growth factors for the treatment of Parkinson’s disease

Yasuda, T., & Mochizuki, H. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.55 · Cited by 41 · see citing works

BDNF provides many routes toward STN DBS‐mediated disease modification

Fischer, D. L., & Sortwell, C. E. (2018) · Movement Disorders · doi:10.1002/mds.27535 · Cited by 38 · see citing works

Peripheral BDNF/TrkB protein expression is decreased in Parkinson’s disease but not in Essential tremor

Huang, Y., Huang, C., & Yun, W. (2019) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2019.01.017 · Cited by 38 · see citing works

Differential signaling of glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor in cultured ventral mesencephalic neurons

Feng, L., Wang, C.-Y., Jiang, H., Oho, C., Dugich‐Djordjevic, M. M., Mei, L., & Lu, B. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00129-3 · Cited by 37 · see citing works

Differential cellular and subcellular localization of protein phosphatase 1 isoforms in brain

Strack, S., Kini, S., Ebner, F. F., Wadzinski, B. E., & Colbran, R. J. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19991025)413:3 · Cited by 87 · see citing works

Therapeutic Potential of Repeated Intravenous Transplantation of Human Adipose-Derived Stem Cells in Subchronic MPTP-Induced Parkinson’s Disease Mouse Model

Park, H., & Chang, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218129 · Cited by 34 · see citing works

Association of a variation in the promoter region of the brain-derived neurotrophic factor gene with familial Parkinson's disease

Parsian, A., Sinha, R. R., Racette, B. A., Zhao, J. H., & Perlmutter, J. S. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2003.12.003 · Cited by 34 · see citing works

Inflammatory Mechanisms in Parkinson’s Disease: From Pathogenesis to Targeted Therapies

Lee, S. Y. H., Yates, N. J., & Tye, S. J. (2021) · The Neuroscientist · doi:10.1177/1073858421992265 · Cited by 33 · see citing works

Challenges and Promises in the Development of Neurotrophic Factor-Based Therapies for Parkinson’s Disease

Rodrigues, T. M., Jerónimo-Santos, A., Outeiro, T. F., Sebastião, A. M., & Diógenes, M. J. (2014) · Drugs & Aging · doi:10.1007/s40266-014-0160-x · Cited by 32 · see citing works

Investigation of tyrosine hydroxylase and BDNF in a low-dose rotenone model of Parkinson's disease

Johnson, M., Lim, Y. P., Senthilkumaran, M., Zhou, X., & Bobrovskaya, L. (2015) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2015.11.002 · Cited by 32 · see citing works

Neurotrophic factors in neurodegenerative disorders: Model of parkinson’s disease

de Yébenes, J. G., & Mena, M. A. (2000) · Neurotoxicity Research · doi:10.1007/bf03033789 · Cited by 31 · see citing works

Neuroscience fundamentals relevant to neuromodulation: Neurobiology of deep brain stimulation in Parkinson's disease

Davidson, B., Milosevic, L., Kondrataviciute, L., Kalia, L. V., & Kalia, S. K. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00348 · Cited by 30 · see citing works

No Association between Brain-Derived Neurotrophic Factor G196A Polymorphism and Clinical Features of Parkinson's Disease

Svetel, M. V., Pekmezovic, T. D., Marković, V., Novaković, I. V., Dobričić, V., Djuric, G., Stefanova, E. D., & Kostić, V. (2013) · European Neurology · doi:10.1159/000352033 · Cited by 30 · see citing works

Brain-Derived Neurotrophic Factor (Val66Met) Polymorphism Does Not Influence Recovery from a Post-Traumatic Vegetative State: A Blinded Retrospective Multi-Centric Study

Bagnato, S., Minafra, L., Bravatà, V., Boccagni, C., Santangelo, A., Castiglione, A., Andriolo, M., Lucca, L. F., TANTI, A. D., Pistarini, C., et al. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2011.2184 · Cited by 30 · see citing works

Neurotrophic Factors and Neurodegenerative Diseases

Ruozi, B., Belletti, D., Bondioli, L., Vita, A. D., Forni, F., Vandelli, M. A., & Tosi, G. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00009-0 · Cited by 29 · see citing works

Strategies for the protection of dopaminergic neurons against neurotoxicity

Gerlach, M., Double, K. L., Youdim, M. B. H., & Riederer, P. (2000) · Neurotoxicity Research · doi:10.1007/bf03033788 · Cited by 29 · see citing works

Electro-Acupuncture Ameliorated MPTP-Induced Parkinsonism in Mice via TrkB Neurotrophic Signaling

Zhao, Y., Luo, D., Ning, Z., Rong, J., & Lao, L. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00496 · Cited by 28 · see citing works

Are TrkB receptor agonists the right tool to fulfill the promises for a therapeutic value of the brain-derived neurotrophic factor?

Zagrebelsky, M., & Körte, M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.374138 · Cited by 28 · see citing works

Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease

Liu, J., Zhou, Y., Wang, C., Wang, T., Zheng, Z., & Chan, P. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.09.002 · Cited by 28 · see citing works

Robust changes in expression of brain-derived neurotrophic factor (BDNF) mRNA and protein across the brain do not translate to detectable changes in BDNF levels in CSF or plasma

Lanz, T. A., Bove, S. E., Pilsmaker, C. D., Mariga, A., Drummond, E. M., Cadelina, G. W., Adamowicz, W. O., Swetter, B. J., Carmel, S., Dumin, J. A., et al. (2012) · Biomarkers · doi:10.3109/1354750x.2012.694476 · Cited by 28 · see citing works

Directed Evolution of Brain-Derived Neurotrophic Factor for Improved Folding and Expression in Saccharomyces cerevisiae

Burns, M. L., Malott, T. M., Metcalf, K. J., Hackel, B. J., Chan, J. R., & Shusta, E. V. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.01466-14 · Cited by 27 · see citing works

Oroxylin A enhances memory consolidation through the brain-derived neurotrophic factor in mice

Kim, D. H., Lee, Y., Lee, H. E., Park, S. J., Jeon, S. J., Jeon, S. J., Cheong, J. H., Shin, C. Y., Son, K. H., & Ryu, J. H. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.09.001 · Cited by 26 · see citing works

MPTP

Royland, J. E., & Langston, J. W. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-477-1_6 · Cited by 26 · see citing works

Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain‐derived neurotrophic factor

Komnig, D., Dagli, T. C., Habib, P., Zeyen, T., Schulz, J. B., & Falkenburger, B. H. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14575 · Cited by 24 · see citing works

Brain-derived neurotrophic factor expression in the substantia nigra does not change after lesions of dopaminergic neurons

Mocchetti, I., Bachis, A., Nosheny, R. L., & Tanda, G. (2007) · Neurotoxicity Research · doi:10.1007/bf03033922 · Cited by 24 · see citing works

Invited review: Utilizing peripheral nerve regenerative elements to repair damage in the CNS

Seblani, N. E., Welleford, A. S., Quintero, J. E., van Horne, C. G., & Gerhardt, G. A. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108623 · Cited by 24 · see citing works

Neurotrophic molecules in the treatment of neurodegenerative disease with focus on the retina: status and perspectives

Unsicker, K. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1585-y · Cited by 23 · see citing works

Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine)-induced mouse model of Parkinson’s disease

Yokoyama, H., Kuroiwa, H., Kasahara, J., & Araki, T. (2011) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2011-1847 · Cited by 21 · see citing works

Implantation of autologous peripheral nerve grafts into the substantia nigra of subjects with idiopathic Parkinson's disease treated with bilateral STN DBS: a report of safety and feasibility

van Horne, C. G., Quintero, J. E., Gurwell, J. A., Wagner, R. P., Slevin, J. T., & Gerhardt, G. A. (2016) · Journal of neurosurgery · doi:10.3171/2016.2.jns151988 · Cited by 22 · see citing works

Histological Effects of Intraputaminal Infusion of Glial Cell Line-Derived Neurotrophic Factor in Parkinson Disease Model Macaque Monkeys

Oiwa, Y., NAKAI, K., & Itakura, T. (2006) · Neurologia medico-chirurgica · doi:10.2176/nmc.46.267 · Cited by 21 · see citing works

Effects of Brain derived neurotrophic factor (BDNF) on substantial nigra dopaminergic neurons in Parkinson dis- ease rats

Lu, Y. (2000)

Intracerebroventricularly-administered 1-methyl-4-phenylpyridinium ion and brain-derived neurotrophic factor affect catecholaminergic nerve terminals and neurogenesis in the hippocampus, striatum and substantia nigra

Behnisch, T., Chen, J.-F., Wang, M., & Zhuang, Y. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.230300 · Cited by 8 · see citing works

Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat

Frim, D. M., Uhler, T. A., Galpern, W. R., Beal, M. F., Breakefield, X. O., & Isacson, O. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.5104 · Cited by 269 · see citing works

Functional recovery in parkinsonian monkeys treated with GDNF

Gash, D. M., Zhang, Z., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P. A., Collins, F., et al. (1996) · Nature · doi:10.1038/380252a0 · Cited by 955 · see citing works